Atrás
También listada como
LZAGF
OTC
Rango del Día
$59.90
$60.71
Rango de 52 Semanas
$55.57
$73.85
Volumen
16,841
Promedio 50D / 200D
$67.17
/
$68.44
Cierre Anterior
$59.66
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 45.1 | 0.4 |
| P/B | 4.7 | 2.9 |
| ROE % | 10.3 | 3.9 |
| Net Margin % | 15.2 | 3.8 |
| Rev Growth 5Y % | 3.6 | 10.0 |
| D/E | 0.5 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$3.65
$3.49 – $3.99
|
12 B | 1 |
| FY2029 |
$3.02
$2.89 – $3.30
|
10 B | 1 |
| FY2028 |
$2.56
$2.45 – $2.79
|
9.1 B | 1 |
Puntos Clave
Revenue grew 3.63% annually over 5 years — modest growth
Earnings grew 49.21% over the past year
ROE of 10.28% — decent returns on equity
Net margin of 15.21% shows strong profitability
Debt/Equity of 0.46 — conservative balance sheet
Negative free cash flow of -194.83M
Crecimiento
Revenue Growth (5Y)
3.63%
Revenue (1Y)-5.12%
Earnings (1Y)49.21%
FCF Growth (3Y)N/A
Calidad
Return on Equity
10.28%
ROIC7.38%
Net Margin15.21%
Op. Margin21.01%
Seguridad
Debt / Equity
0.46
Current Ratio2.24
Interest Coverage8.09
Valoración
P/E Ratio
45.08
P/B Ratio4.68
EV/EBITDA35.30
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5.12% | Revenue Growth (3Y) | -3.64% |
| Earnings Growth (1Y) | 49.21% | Earnings Growth (3Y) | 20.46% |
| Revenue Growth (5Y) | 3.63% | Earnings Growth (5Y) | -24.65% |
| Profitability | |||
| Revenue (TTM) | 6.24B | Net Income (TTM) | 949.00M |
| ROE | 10.28% | ROA | 5.00% |
| Gross Margin | 37.02% | Operating Margin | 21.01% |
| Net Margin | 15.21% | Free Cash Flow (TTM) | -194.83M |
| ROIC | 7.38% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.46 | Current Ratio | 2.24 |
| Interest Coverage | 8.09 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 45.08 | P/B Ratio | 4.68 |
| P/S Ratio | 6.86 | PEG Ratio | 0.74 |
| EV/EBITDA | 35.30 | Dividend Yield | 0.01% |
| Market Cap | 42.78B | Enterprise Value | 46.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.24B | 6.57B | 6.72B | 6.22B | 5.41B |
| Net Income | 949.00M | 636.00M | 654.00M | 1.22B | 2.94B |
| EPS (Diluted) | 1.35 | 0.89 | 0.89 | 1.63 | 3.95 |
| Gross Profit | 2.31B | 2.16B | 1.95B | 2.44B | 2.11B |
| Operating Income | 1.31B | 964.00M | 880.00M | 1.54B | 851.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 18.97B | 19.73B | 16.85B | 17.36B | 16.46B |
| Total Liabilities | 9.78B | 10.35B | 7.34B | 6.69B | 6.64B |
| Shareholders' Equity | 9.13B | 9.33B | 9.45B | 10.60B | 9.75B |
| Total Debt | 4.19B | 5.12B | 3.13B | 2.59B | 2.75B |
| Cash & Equivalents | 719.00M | 1.11B | 1.47B | 1.34B | 1.58B |
| Current Assets | 8.00B | 5.44B | 4.90B | 5.71B | 5.93B |
| Current Liabilities | 3.57B | 3.58B | 2.76B | 3.08B | 2.37B |